Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
Department of Health and Human Services
The purpose of this notice of funding opportunity (NOFO) is to elucidate the key components of the therapeutic effects of rapid-acting psychotropic interventional drugs (RAPIDs) by addressing the methodological challenges involved with these clinical trials. In addition, this NOFO seeks to advance understanding of how RAPIDs and adjunctive psychosocial interventions can be optimally delivered, monitored, and sustained over time to enhance effectiveness and generalizability. The NOFO will support studies designed to enhance the rigor of RAPID clinical trial design, which will ultimately increase the interpretability of the data and the generalizability of the results.
Funding
Award size
Not specified
Type
Grant
Dates
Deadline
Next 90 days
Posted
04/29/2026
Closes
2026-10-11
Eligibility
Eligibility
Private institutions of higher educationNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationSmall businessesState governmentsPublic housing authorities/Indian housing authoritiesCounty governmentsOthers (see text field entitled "Additional Information on Eligibility" for clarification)Special district governmentsCity or township governmentsIndependent school districtsNative American tribal governments (Federally recognized)Public and State controlled institutions of higher educationNative American tribal organizations (other than Federally recognized tribal governments)For profit organizations other than small businesses
Program
Funding area
Health - HL
Opportunity #
RFA-MH-27-135
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov